Qifu fends off short-seller assault over its earnings record
The online loan facilitator found itself under fire from Grizzly Research, accused of inflating its profits, but the claims failed to dent the company’s share price or deliver a resounding…
China Securities Regulator Takes on VIEs. Now It Needs to Address Depositary Receipts
The popular form of shares for overseas-listed firms provides nice profits for companies that use them, but are less advantageous for shareholders By George H. Gregor Chinese companies often use…
U.S.-listed Chinese Stocks May Be Set for Rebound in 2022
After a year of setbacks, Chinese stocks traded in New York and Hong Kong are regaining investor interest as the policy landscape becomes clearer Key takeaways: The regulatory storm that…
China Comes Out in Support of Continued U.S. Listings – With Stronger Oversight
Country’s securities regulator issues draft document saying it will use a registration system to allow continued listings of Chinese firms overseas Key Takeaways: China’s securities regulator has announced its intent…
Chinese Wheelchair Maker Tests U.S. Regulator’s Appetite for Controversial VIE Structure
Jin Medical is first Chinese firm using the variable interest entity (VIE) structure to apply for a New York IPO since the U.S. regulator temporarily banned such listings earlier this…
Recent Articles
RELATED ARTICLES
-
Forget about growth. Qifu shows it’s all about giving back to shareholders
QFIN.US - Once branded a copycat jeweler, Zhou Liu Fu seeks gold in Hong Kong
-
JD.com eyes tricky consumer finance business with pending acquisition
JD.US 9618.HK
- Payment app Lianlian seeks IPO relief from cash crunch
-
Investors unimpressed by massive dividend from shrinking Lufax
6623.HK LU.US
-
Lufax takes on more risk, makes Hong Kong acquisition, as its lending shrivels
6623.HK LU.US
-
Is Youdao finally learning how to earn profits?
DAO.US
